MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
17.96
-1.45 (-7.47%)
At close: Apr 10, 2026, 4:00 PM EDT
18.37
+0.41 (2.29%)
After-hours: Apr 10, 2026, 7:51 PM EDT

MLTX Stock Forecast

Stock Price Forecast

The 12 analysts that cover MLTX stock have a consensus rating of "Buy" and an average price target of $27.5, which forecasts a 53.12% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $70.

Price Target: $27.5 (+53.12%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.00$27.5$25$70
Change-72.16%+53.12%+39.20%+289.76%

Analyst Ratings

The average analyst rating for MLTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Mar '26
Strong Buy444466
Buy222333
Hold221111
Sell000000
Strong Sell112222
Total999101212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Reiterates
$30
Strong BuyReiterates$30+67.04%Mar 30, 2026
Wolfe Research
Wolfe Research
Buy
Upgrades
$12$24
BuyUpgrades$12$24+33.63%Mar 23, 2026
Rothschild & Co
Rothschild & Co
Strong Buy
Upgrades
$12$40
Strong BuyUpgrades$12$40+122.72%Mar 19, 2026
Clear Street
Clear Street
Strong Buy
Maintains
$45$70
Strong BuyMaintains$45$70+289.76%Mar 11, 2026
RBC Capital
RBC Capital
Hold
Maintains
$12$13
HoldMaintains$12$13-27.62%Mar 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
20.74M
EPS This Year
-3.69
from -3.53
EPS Next Year
-3.74
from -3.69
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
------20.74M
Revenue Growth
-------
EPS
-8.21-1.70-0.73-1.89-3.53-3.69-3.74
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1713
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/a43.6M
Avgn/a20.7M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-2.66-2.73
Avg-3.69-3.74
Low-4.16-5.10

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.